Sale!

ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the ATR gene, which are associated with an increased risk of developing cutaneous telangiectasia and various forms of cancer. This test is particularly important for individuals with a family history of these conditions, as it can provide crucial information regarding their genetic predisposition to these diseases.

Cutaneous telangiectasia refers to the visible dilation of small blood vessels near the skin’s surface, which can be an indicator of underlying genetic conditions, including those that predispose individuals to cancer. The ATR gene plays a significant role in DNA repair and cell cycle regulation; mutations in this gene can compromise the body’s ability to repair DNA damage, leading to an increased risk of cancer.

The test is conducted using a sample of the patient’s blood or saliva, which is then analyzed in the state-of-the-art facilities of DNA Labs UAE. The process involves examining the genetic material for specific mutations in the ATR gene that are known to contribute to the development of cutaneous telangiectasia and cancer syndrome.

The cost of the ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial Genetic Test at DNA Labs UAE is 4400 AED. While the test may represent a significant investment, it offers invaluable insights into an individual’s genetic health, potentially guiding preventive measures and personalized treatment strategies to mitigate the risk of developing associated conditions.

Description

ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial Genetic Test

Genetic testing is an essential tool in identifying and diagnosing various genetic disorders. One such disorder is Cutaneous Telangiectasia and Cancer Syndrome, Familial (CTC Syndrome), which is associated with the ATR gene.

CTC Syndrome is a rare genetic disorder characterized by the development of multiple blood vessel abnormalities called telangiectasias on the skin and mucous membranes. Individuals with CTC Syndrome also have an increased risk of developing various types of cancer, including leukemia, lymphoma, and solid tumors.

NGS (Next-Generation Sequencing) Genetic Testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of CTC Syndrome, NGS Genetic Testing can be used to identify mutations or variations in the ATR gene that may be responsible for the development of the condition.

At DNA Labs UAE, we offer the ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial Genetic Test at a cost of AED 4400.0. The test requires a sample condition of blood or extracted DNA or one drop of blood on an FTA card. The report delivery takes approximately 3 to 4 weeks.

The test is conducted using NGS Technology, which allows for accurate and efficient analysis of the ATR gene. The test falls under the category of Cancer Genetic Testing and is conducted by our team of experienced oncologists in the Genetics department.

Prior to the test, it is important to provide the clinical history of the patient who is going for the ATR Gene Cutaneous Telangiectasia and Cancer Syndrome Familial NGS Genetic DNA Test. Additionally, a genetic counseling session is conducted to draw a pedigree chart of family members affected with the ATR gene and CTC Syndrome.

It is crucial to note that genetic testing for CTC Syndrome should only be performed by qualified healthcare professionals or genetic counselors who can interpret the results accurately and provide appropriate guidance and support.

By analyzing the ATR gene using NGS technology, healthcare professionals can identify specific genetic changes that may be present in individuals suspected of having CTC Syndrome. This information can help in confirming a diagnosis, providing appropriate medical management, and offering genetic counseling to affected individuals and their families.

Test Name	ATR Gene Cutaneous telangiectasia and cancer syndrome familial Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cancer
Doctor	Oncologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ATR Gene Cutaneous telangiectasia and cancer syndrome, familial NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ATR Gene Cutaneous telangiectasia and cancer syndrome, familial NGS Genetic DNA Test gene ATR
Test Details	The ATR gene is associated with a condition called Cutaneous Telangiectasia and Cancer Syndrome, Familial (CTC Syndrome). This syndrome is a rare genetic disorder characterized by the development of multiple blood vessel abnormalities called telangiectasias on the skin and mucous membranes. Individuals with CTC Syndrome also have an increased risk of developing various types of cancer, including leukemia, lymphoma, and solid tumors. NGS (Next-Generation Sequencing) Genetic Testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of CTC Syndrome, NGS Genetic Testing can be used to identify mutations or variations in the ATR gene that may be responsible for the development of the condition. By analyzing the ATR gene using NGS technology, healthcare professionals can identify specific genetic changes that may be present in individuals suspected of having CTC Syndrome. This information can help in confirming a diagnosis, providing appropriate medical management, and offering genetic counseling to affected individuals and their families. It’s important to note that genetic testing for CTC Syndrome should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.